Mirae Asset Global Investments Co., Ltd. Intercept Pharmaceuticals, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	BUY	$9.99 - $18.71 $107,762 - $201,824	10,787 Added 41.64%	36,690 $680,000
Q2 2023 Aug 10, 2023	BUY	$9.17 - $19.29 $38,055 - $80,053	4,150 Added 19.08%	25,903 $286,000
Q1 2023 May 04, 2023	BUY	$12.53 - $21.71 $123,345 - $213,713	9,844 Added 82.66%	21,753 $292,000
Q4 2022 Feb 09, 2023	BUY	$11.61 - $16.11 $3,529 - $4,897	304 Added 2.62%	11,909 $147,000
Q3 2022 Nov 10, 2022	BUY	$12.21 - $19.7 $141,697 - $228,618	11,605 New	11,605 $162,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.